BVF PARTNERS L P/IL Insider Trading
Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is in Capstone Therapeutics Corp. ($CAPS) and 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in CTI BIOPHARMA CORP ($CTIC) and 10% Owner in XOMA Corp ($XOMA) and Director in XOMA Corp ($XOMA) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in INFINITY PHARMACEUTICALS, INC. ($INFI) and in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and 10% Owner in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and in CYTOKINETICS INC ($CYTK) and 10% Owner in CYTOKINETICS INC ($CYTK) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in CONCERT PHARMACEUTICALS, INC. ($CNCE) and 10% Owner in Syndax Pharmaceuticals Inc ($SNDX) and in Eledon Pharmaceuticals, Inc. ($NVUS) and in ChemoCentryx, Inc. ($CCXI) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in IMMUNE DESIGN CORP. ($IMDZ) and 10% Owner in Calithera Biosciences, Inc. ($CALA) and 10% Owner in Principia Biopharma Inc. ($PRNB) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and 10% Owner in Xenon Pharmaceuticals Inc. ($XENE) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Merus N.V. ($MRUS) and in IDEAYA Biosciences, Inc. ($IDYA) and 10% Owner in IDEAYA Biosciences, Inc. ($IDYA) and Director in Olema Pharmaceuticals, Inc. ($OLMA) and Director in Kymera Therapeutics, Inc. ($KYMR). Discover the current value of BVF PARTNERS L P/IL shares.
Address:
BVF PARTNERS L P/IL is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
CCXI | ChemoCentryx, Inc. | 0 | 0.00 | |
CTIC | CTI BIOPHARMA CORP | Director, 10% Owner | 4,085,933 | 19,081,307.11 |
INFI | INFINITY PHARMACEUTICALS, INC. | 10% Owner | 5,663,912 | 13,310,193.20 |
ALPN | ALPINE IMMUNE SCIENCES, INC. | 10% Owner | 1,109,258 | 2,595,663.72 |
XENE | Xenon Pharmaceuticals Inc. | 10% Owner | 336,468 | 2,759,037.60 |
CAPS | Capstone Therapeutics Corp. | 0 | 0.00 | |
CNCE | CONCERT PHARMACEUTICALS, INC. | 10% Owner | 1,178,904 | 10,551,190.80 |
ARQL | ARQULE INC | 10% Owner | 4,682,669 | 6,415,256.53 |
SNDX | Syndax Pharmaceuticals Inc | 10% Owner | 498,025 | 4,327,837.25 |
XOMA | XOMA Corp | Director, 10% Owner | 200,000 | 842,000.00 |
IMDZ | IMMUNE DESIGN CORP. | 10% Owner | 2,502,758 | 13,264,617.40 |
PIRS | PIERIS PHARMACEUTICALS, INC. | 10% Owner | 2,385,055 | 5,247,121.00 |
GLYC | GLYCOMIMETICS INC | 10% Owner | 4,306,320 | 26,957,563.20 |
FPRX | FIVE PRIME THERAPEUTICS, INC. | 670,695 | 30,436,139.10 | |
CALA | Calithera Biosciences, Inc. | 10% Owner | 3,712,340 | 33,782,294.00 |
CYTK | CYTOKINETICS INC | 3,811,271 | 44,591,870.70 | |
MRUS | Merus N.V. | 10% Owner | 3,803,152 | 91,161,553.44 |
IDYA | IDEAYA Biosciences, Inc. | 1,642,186 | ||
PRNB | Principia Biopharma Inc. | 10% Owner | 0 | |
KYMR | Kymera Therapeutics, Inc. | Director | 837,916 | |
OLMA | Olema Pharmaceuticals, Inc. | Director | 1,129,404 | |
ELDN | Eledon Pharmaceuticals, Inc. | 117,565 | 106,984.15 |
Insider Trading Transactions of BVF PARTNERS L P/IL
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Apr 05 2021 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | Director | Buy | 2.50 | 1,044,813 | 2,612,033 | 4,085,933 |
Apr 05 2021 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | Director | Buy | 2.50 | 950,016 | 2,375,040 | 3,059,296 |
Apr 05 2021 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | Director | Buy | 2.50 | 5,171 | 12,928 | 488,879 |
Apr 05 2021 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | Director | Option Exercise | 0.00 | 344 | 0 | 344 |
Apr 05 2021 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | Director | Option Exercise | 0.00 | 239 | 0 | 239 |
Apr 05 2021 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | Director | Option Exercise | 0.00 | 17 | 0 | 17 |
Apr 01 2021 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 19.75 | 165,000 | 3,258,750 | 3,803,152 |
Apr 01 2021 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 19.75 | 108,106 | 2,135,094 | 2,892,385 |
Apr 01 2021 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 19.75 | 26,894 | 531,157 | 462,015 |
Mar 24 2021 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 22.75 | 71,756 | 1,632,449 | 3,638,152 |
Mar 24 2021 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 22.75 | 7,744 | 176,176 | 435,121 |
Mar 18 2021 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 23.00 | 53,061 | 1,220,382 | 3,566,396 |
Mar 18 2021 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 23.00 | 195,768 | 4,502,586 | 2,784,279 |
Mar 18 2021 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 23.00 | 1,171 | 26,933 | 427,377 |
Mar 12 2021 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | Director | Option Exercise | 3.30 | 80,000 | 264,000 | 80,000 |
Feb 04 2021 | IDYA | IDEAYA Biosciences, Inc. | BVF PARTNERS L P/IL | Sell | 18.00 | 25,234 | 454,212 | 1,642,186 | |
Feb 04 2021 | IDYA | IDEAYA Biosciences, Inc. | BVF PARTNERS L P/IL | Sell | 18.00 | 16,850 | 303,300 | 1,188,131 | |
Feb 04 2021 | IDYA | IDEAYA Biosciences, Inc. | BVF PARTNERS L P/IL | Sell | 18.00 | 4,325 | 77,850 | 233,150 | |
Jan 26 2021 | INFI | INFINITY PHARMACEUTICALS, ... | BVF PARTNERS L P/IL | 10% Owner | Sell | 4.14 | 2,821,663 | 11,678,299 | 5,663,912 |
Jan 26 2021 | INFI | INFINITY PHARMACEUTICALS, ... | BVF PARTNERS L P/IL | 10% Owner | Sell | 4.14 | 2,458,838 | 10,176,639 | 4,172,298 |
Jan 26 2021 | INFI | INFINITY PHARMACEUTICALS, ... | BVF PARTNERS L P/IL | 10% Owner | Sell | 4.14 | 568,019 | 2,350,917 | 686,974 |
Jan 25 2021 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 24.75 | 457,814 | 11,330,897 | 3,513,335 |
Jan 25 2021 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 24.75 | 343,444 | 8,500,239 | 2,588,511 |
Jan 25 2021 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 24.75 | 43,422 | 1,074,695 | 426,206 |
Dec 28 2020 | NVUS | Eledon Pharmaceuticals, I ... | BVF PARTNERS L P/IL | Buy | 0.00 | 15,166 | 0 | 117,565 | |
Dec 28 2020 | NVUS | Eledon Pharmaceuticals, I ... | BVF PARTNERS L P/IL | Buy | 0.00 | 654,215 | 0 | 771,780 | |
Dec 28 2020 | NVUS | Eledon Pharmaceuticals, I ... | BVF PARTNERS L P/IL | Buy | 0.00 | 11,278 | 0 | 89,214 | |
Dec 28 2020 | NVUS | Eledon Pharmaceuticals, I ... | BVF PARTNERS L P/IL | Buy | 0.00 | 509,410 | 0 | 598,624 | |
Dec 28 2020 | NVUS | Eledon Pharmaceuticals, I ... | BVF PARTNERS L P/IL | Buy | 0.00 | 1,944 | 0 | 15,537 | |
Dec 28 2020 | NVUS | Eledon Pharmaceuticals, I ... | BVF PARTNERS L P/IL | Buy | 0.00 | 97,615 | 0 | 113,152 | |
Dec 28 2020 | NVUS | Eledon Pharmaceuticals, I ... | BVF PARTNERS L P/IL | Option Exercise | 0.00 | 273 | 0 | 0 | |
Dec 28 2020 | NVUS | Eledon Pharmaceuticals, I ... | BVF PARTNERS L P/IL | Option Exercise | 0.00 | 203 | 0 | 0 | |
Dec 28 2020 | NVUS | Eledon Pharmaceuticals, I ... | BVF PARTNERS L P/IL | Option Exercise | 0.00 | 35 | 0 | 0 | |
Dec 28 2020 | NVUS | Eledon Pharmaceuticals, I ... | BVF PARTNERS L P/IL | Option Exercise | 0.00 | 11,776 | 0 | 52,145 | |
Dec 28 2020 | NVUS | Eledon Pharmaceuticals, I ... | BVF PARTNERS L P/IL | Option Exercise | 0.00 | 9,169 | 0 | 39,693 | |
Dec 28 2020 | NVUS | Eledon Pharmaceuticals, I ... | BVF PARTNERS L P/IL | Option Exercise | 0.00 | 1,757 | 0 | 6,758 | |
Dec 22 2020 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 16.05 | 114,968 | 1,845,236 | 3,055,521 |
Dec 22 2020 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 16.05 | 45,032 | 722,764 | 2,245,067 |
Dec 15 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | 25.00 | 200,000 | 5,000,000 | 200,000 |
Dec 11 2020 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | Sell | 18.00 | 239,274 | 4,306,932 | 3,811,271 | |
Dec 11 2020 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | Sell | 18.00 | 166,194 | 2,991,492 | 2,760,185 | |
Dec 11 2020 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | Sell | 18.00 | 25,486 | 458,748 | 463,244 | |
Nov 20 2020 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | Option Exercise | 20.00 | 740 | 14,800 | 0 | |
Nov 20 2020 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | Option Exercise | 20.00 | 551 | 11,020 | 0 | |
Nov 20 2020 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | Option Exercise | 20.00 | 93 | 1,860 | 0 | |
Nov 20 2020 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | Option Exercise | 20.00 | 740 | 14,800 | 0 | |
Nov 20 2020 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | Option Exercise | 20.00 | 551 | 11,020 | 0 | |
Nov 20 2020 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | Option Exercise | 20.00 | 93 | 1,860 | 0 | |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Buy | 0.00 | 1,129,404 | 0 | 1,129,404 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Buy | 0.00 | 889,186 | 0 | 2,018,590 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Buy | 0.00 | 760,155 | 0 | 2,778,745 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Buy | 19.00 | 613,918 | 11,664,442 | 3,392,663 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Buy | 0.00 | 881,156 | 0 | 881,156 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Buy | 0.00 | 673,281 | 0 | 1,554,437 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Buy | 0.00 | 522,403 | 0 | 2,076,840 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Buy | 19.00 | 446,425 | 8,482,075 | 2,523,265 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Buy | 0.00 | 185,908 | 0 | 185,908 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Buy | 0.00 | 101,784 | 0 | 287,692 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Buy | 0.00 | 73,399 | 0 | 361,091 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Buy | 19.00 | 74,991 | 1,424,829 | 436,082 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Option Exercise | 19.00 | 21,520 | 408,880 | 21,520 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Option Exercise | 19.00 | 21,520 | 408,880 | 21,520 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Option Exercise | 19.00 | 21,520 | 408,880 | 21,520 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Option Exercise | 0.00 | 1,129,404 | 0 | 0 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Option Exercise | 0.00 | 881,156 | 0 | 0 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Buy | 0.00 | 1,129,404 | 0 | 1,129,404 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Option Exercise | 0.00 | 185,908 | 0 | 0 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Buy | 0.00 | 889,186 | 0 | 2,018,590 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Option Exercise | 0.00 | 889,186 | 0 | 0 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Buy | 0.00 | 760,155 | 0 | 2,778,745 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Option Exercise | 0.00 | 673,281 | 0 | 0 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Buy | 19.00 | 613,918 | 11,664,442 | 3,392,663 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Option Exercise | 0.00 | 101,784 | 0 | 0 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Buy | 0.00 | 881,156 | 0 | 881,156 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Option Exercise | 0.00 | 760,155 | 0 | 0 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Buy | 0.00 | 673,281 | 0 | 1,554,437 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Option Exercise | 0.00 | 522,403 | 0 | 0 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Buy | 0.00 | 522,403 | 0 | 2,076,840 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Option Exercise | 0.00 | 73,399 | 0 | 0 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Buy | 19.00 | 446,425 | 8,482,075 | 2,523,265 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Buy | 0.00 | 185,908 | 0 | 185,908 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Buy | 0.00 | 101,784 | 0 | 287,692 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Buy | 0.00 | 73,399 | 0 | 361,091 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Buy | 19.00 | 74,991 | 1,424,829 | 436,082 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Option Exercise | 19.00 | 21,520 | 408,880 | 21,520 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Option Exercise | 19.00 | 21,520 | 408,880 | 21,520 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Option Exercise | 19.00 | 21,520 | 408,880 | 21,520 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Option Exercise | 0.00 | 1,129,404 | 0 | 0 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Option Exercise | 0.00 | 881,156 | 0 | 0 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Option Exercise | 0.00 | 185,908 | 0 | 0 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Option Exercise | 0.00 | 889,186 | 0 | 0 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Option Exercise | 0.00 | 673,281 | 0 | 0 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Option Exercise | 0.00 | 101,784 | 0 | 0 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Option Exercise | 0.00 | 760,155 | 0 | 0 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Option Exercise | 0.00 | 522,403 | 0 | 0 |
Nov 20 2020 | OLMA | Olema Pharmaceuticals, In ... | BVF PARTNERS L P/IL | Director | Option Exercise | 0.00 | 73,399 | 0 | 0 |
Nov 13 2020 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | Sell | 20.19 | 3,941,214 | 79,560,105 | 670,695 | |
Nov 13 2020 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | Sell | 20.19 | 2,949,477 | 59,540,207 | 485,513 | |
Nov 13 2020 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | Sell | 20.19 | 502,649 | 10,146,825 | 81,263 | |
Nov 03 2020 | GLYC | GLYCOMIMETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | 2.75 | 666,385 | 1,832,559 | 4,306,320 |
Nov 03 2020 | GLYC | GLYCOMIMETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | 2.75 | 250,755 | 689,576 | 3,206,195 |
Nov 03 2020 | GLYC | GLYCOMIMETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | 2.75 | 15,472 | 42,548 | 544,363 |
Nov 03 2020 | GLYC | GLYCOMIMETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | 2.75 | 666,385 | 1,832,559 | 4,306,320 |
Nov 03 2020 | GLYC | GLYCOMIMETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | 2.75 | 250,755 | 689,576 | 3,206,195 |
Nov 03 2020 | GLYC | GLYCOMIMETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | 2.75 | 15,472 | 42,548 | 544,363 |
Oct 08 2020 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 5.04 | 157,782 | 794,432 | 4,336,875 |
Oct 08 2020 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 5.04 | 162,352 | 817,442 | 3,281,151 |
Oct 08 2020 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 5.04 | 25,107 | 126,414 | 566,223 |
Sep 24 2020 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 3.80 | 32 | 122 | 541,116 |
Sep 23 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | 18.39 | 12,259 | 225,383 | 2,023,276 |
Sep 23 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | 18.45 | 6,960 | 128,382 | 2,030,236 |
Sep 23 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | 18.20 | 9,888 | 179,960 | 2,040,124 |
Sep 23 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | 18.39 | 10,069 | 185,120 | 1,738,512 |
Sep 23 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | 18.45 | 4,991 | 92,062 | 1,743,503 |
Sep 23 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | 18.20 | 7,201 | 131,057 | 1,750,704 |
Sep 17 2020 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 11.75 | 77,751 | 913,574 | 2,940,553 |
Sep 17 2020 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 11.75 | 58,745 | 690,254 | 2,200,035 |
Sep 17 2020 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 11.75 | 10,258 | 120,532 | 382,784 |
Sep 14 2020 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 11.10 | 100,461 | 1,114,936 | 2,862,802 |
Sep 14 2020 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 11.10 | 76,374 | 847,614 | 2,141,290 |
Sep 14 2020 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 11.10 | 12,816 | 142,235 | 372,526 |
Sep 10 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | 18.77 | 3,907 | 73,337 | 2,011,017 |
Sep 10 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | 18.77 | 3,830 | 71,891 | 1,728,443 |
Sep 08 2020 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 11.17 | 104,827 | 1,170,918 | 2,762,341 |
Sep 08 2020 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 11.17 | 82,740 | 924,206 | 2,064,916 |
Sep 08 2020 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 11.17 | 14,339 | 160,167 | 359,710 |
Sep 01 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | 19.17 | 1,122 | 21,511 | 1,988,067 |
Sep 01 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | 18.48 | 9,143 | 168,968 | 1,997,210 |
Sep 01 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | 18.87 | 9,900 | 186,774 | 2,007,110 |
Sep 01 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | 19.17 | 922 | 17,676 | 1,710,079 |
Sep 01 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | 18.48 | 6,862 | 126,814 | 1,716,941 |
Sep 01 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | 18.87 | 7,672 | 144,741 | 1,724,613 |
Aug 25 2020 | KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | Buy | 0.00 | 837,916 | 0 | 837,916 |
Aug 25 2020 | KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | Buy | 20.00 | 521,193 | 10,423,860 | 1,359,109 |
Aug 25 2020 | KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | Buy | 0.00 | 627,598 | 0 | 627,598 |
Aug 25 2020 | KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | Buy | 20.00 | 389,709 | 7,794,180 | 1,017,307 |
Aug 25 2020 | KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | Buy | 0.00 | 113,290 | 0 | 113,290 |
Aug 25 2020 | KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | Buy | 20.00 | 67,791 | 1,355,820 | 181,081 |
Aug 25 2020 | KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | Option Exercise | 20.00 | 40,127 | 802,540 | 40,127 |
Aug 25 2020 | KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | Option Exercise | 0.00 | 1,336,390 | 0 | 0 |
Aug 25 2020 | KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | Option Exercise | 0.00 | 1,000,955 | 0 | 0 |
Aug 25 2020 | KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Director | Option Exercise | 0.00 | 180,686 | 0 | 0 |
Aug 25 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | 19.32 | 9,198 | 177,720 | 1,976,998 |
Aug 25 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | 19.31 | 6,504 | 125,588 | 1,983,502 |
Aug 25 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | 19.75 | 3,443 | 67,982 | 1,986,945 |
Aug 25 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | 19.32 | 1,607 | 31,050 | 1,701,734 |
Aug 25 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | 19.31 | 5,179 | 100,003 | 1,706,913 |
Aug 25 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | 19.75 | 2,244 | 44,308 | 1,709,157 |
Aug 20 2020 | PRNB | Principia Biopharma Inc. | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | 100.00 | 1,205 | 120,500 | 27,265 |
Aug 20 2020 | PRNB | Principia Biopharma Inc. | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | 100.00 | 905 | 90,500 | 20,390 |
Aug 20 2020 | PRNB | Principia Biopharma Inc. | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | 100.00 | 158 | 15,800 | 3,547 |
Aug 20 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Buy | 19.27 | 895 | 17,246 | 1,962,532 |
Aug 20 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Buy | 19.70 | 3,496 | 68,877 | 1,966,028 |
Aug 20 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Buy | 19.12 | 1,772 | 33,881 | 1,967,800 |
Aug 14 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Buy | 17.34 | 4,050 | 70,233 | 1,938,665 |
Aug 14 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Buy | 17.80 | 1,050 | 18,693 | 1,939,715 |
Aug 14 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Buy | 18.69 | 21,922 | 409,810 | 1,961,637 |
Jul 02 2020 | IDYA | IDEAYA Biosciences, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | 13.32 | 1,521 | 20,254 | 1,667,420 |
Jul 02 2020 | IDYA | IDEAYA Biosciences, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | 13.32 | 929 | 12,371 | 1,204,981 |
Jul 02 2020 | IDYA | IDEAYA Biosciences, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | 13.32 | 81 | 1,079 | 237,475 |
Jun 22 2020 | IDYA | IDEAYA Biosciences, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | 14.39 | 52,443 | 754,629 | 1,655,375 |
Jun 22 2020 | IDYA | IDEAYA Biosciences, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | 14.39 | 39,052 | 561,939 | 1,196,198 |
Jun 22 2020 | IDYA | IDEAYA Biosciences, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | 14.39 | 6,769 | 97,403 | 236,040 |
Jun 22 2020 | IDYA | IDEAYA Biosciences, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | 13.93 | 10,524 | 146,649 | 1,665,899 |
Jun 22 2020 | IDYA | IDEAYA Biosciences, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | 13.93 | 7,854 | 109,443 | 1,204,052 |
Jun 22 2020 | IDYA | IDEAYA Biosciences, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | 13.93 | 1,354 | 18,868 | 237,394 |
Jun 10 2020 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 15.20 | 46,966 | 713,883 | 2,657,514 |
Jun 10 2020 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 15.20 | 33,321 | 506,479 | 1,982,176 |
Jun 10 2020 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 15.20 | 6,967 | 105,898 | 345,371 |
Jun 03 2020 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 14.00 | 806,443 | 11,290,202 | 2,610,548 |
Jun 03 2020 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 14.00 | 561,966 | 7,867,524 | 1,948,855 |
Jun 03 2020 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 14.00 | 94,101 | 1,317,414 | 338,404 |
May 26 2020 | CALA | Calithera Biosciences, In ... | BVF PARTNERS L P/IL | 10% Owner | Sell | 6.00 | 1,027,016 | 6,162,096 | 3,712,340 |
May 26 2020 | CALA | Calithera Biosciences, In ... | BVF PARTNERS L P/IL | 10% Owner | Sell | 6.00 | 1,064,332 | 6,385,992 | 2,766,561 |
May 26 2020 | CALA | Calithera Biosciences, In ... | BVF PARTNERS L P/IL | 10% Owner | Sell | 6.00 | 192,250 | 1,153,500 | 480,432 |
May 18 2020 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 4.10 | 249,301 | 1,022,134 | 4,179,093 |
May 18 2020 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 4.10 | 39,810 | 163,221 | 3,118,799 |
May 18 2020 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 4.10 | 4,476 | 18,352 | 541,084 |
Apr 17 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Buy | 13.00 | 655,959 | 8,527,467 | 1,934,615 |
Apr 17 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Buy | 13.00 | 596,813 | 7,758,569 | 1,700,127 |
Apr 17 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | 13.00 | 656 | 8,528 | 0 |
Apr 17 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | 13.00 | 597 | 7,761 | 0 |
Mar 27 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Buy | 17.20 | 8,264 | 142,129 | 1,278,656 |
Mar 20 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Buy | 14.52 | 4,439 | 64,475 | 1,270,392 |
Mar 20 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Buy | 14.52 | 4,439 | 64,475 | 1,270,392 |
Mar 17 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Buy | 18.34 | 100,000 | 1,834,090 | 1,247,676 |
Mar 17 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Buy | 15.73 | 10,164 | 159,916 | 1,257,840 |
Mar 17 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Buy | 15.73 | 8,113 | 127,648 | 1,265,953 |
Mar 04 2020 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | 10,000.00 | 613 | 6,130,000 | 0 |
Mar 04 2020 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | 10,000.00 | 613 | 6,130,000 | 613 |
Mar 04 2020 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | 10,000.00 | 409 | 4,090,000 | 0 |
Mar 04 2020 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | 10,000.00 | 409 | 4,090,000 | 409 |
Mar 04 2020 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | 10,000.00 | 104 | 1,040,000 | 0 |
Mar 04 2020 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | 10,000.00 | 104 | 1,040,000 | 104 |
Mar 04 2020 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | 10,000.00 | 981 | 9,810,000 | 1,594 |
Mar 04 2020 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | 10,000.00 | 841 | 8,410,000 | 1,250 |
Mar 04 2020 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | 10,000.00 | 87 | 870,000 | 191 |
Mar 04 2020 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | 10,000.00 | 12 | 120,000 | 12 |
Feb 18 2020 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | 10% Owner | Sell | 15.79 | 486,344 | 7,677,815 | 3,131,432 |
Feb 18 2020 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | 10% Owner | Sell | 15.79 | 510,793 | 8,063,787 | 2,350,829 |
Feb 18 2020 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | 10% Owner | Sell | 15.79 | 74,893 | 1,182,321 | 424,419 |
Jan 21 2020 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 16.15 | 146,442 | 2,365,038 | 1,804,105 |
Jan 21 2020 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 16.15 | 112,561 | 1,817,860 | 1,386,889 |
Jan 21 2020 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 16.15 | 19,727 | 318,591 | 244,303 |
Jan 15 2020 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 14.98 | 53,448 | 800,566 | 1,657,663 |
Jan 15 2020 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 14.98 | 25,108 | 376,078 | 1,274,328 |
Jan 15 2020 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% Owner | Buy | 14.98 | 5,406 | 80,973 | 224,576 |
Dec 26 2019 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 4.05 | 281,318 | 1,139,338 | 3,929,792 |
Dec 26 2019 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 4.05 | 201,096 | 814,439 | 3,078,989 |
Dec 26 2019 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 4.05 | 32,606 | 132,054 | 536,608 |
Dec 20 2019 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Buy | 22.00 | 245,481 | 5,400,582 | 940,442 |
Dec 20 2019 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Buy | 22.00 | 190,899 | 4,199,778 | 937,353 |
Dec 20 2019 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Buy | 22.00 | 35,888 | 789,536 | 159,537 |
Dec 20 2019 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Buy | 22.00 | 207,234 | 4,559,148 | 1,147,676 |
Dec 20 2019 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Buy | 22.00 | 165,961 | 3,651,142 | 1,103,314 |
Dec 20 2019 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | 22.00 | 245,481 | 5,400,582 | 0 |
Dec 20 2019 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | 22.00 | 190,899 | 4,199,778 | 0 |
Dec 20 2019 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | 22.00 | 35,888 | 789,536 | 0 |
Dec 12 2019 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | 9.40 | 113,529 | 1,067,173 | 3,557,673 |
Dec 12 2019 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | 9.40 | 95,100 | 893,940 | 2,811,818 |
Dec 12 2019 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | 9.40 | 15,030 | 141,282 | 490,806 |
Dec 12 2019 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | 9.52 | 60,103 | 571,880 | 3,617,776 |
Dec 12 2019 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | 9.52 | 49,804 | 473,885 | 2,861,622 |
Dec 12 2019 | CYTK | CYTOKINETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | 9.52 | 8,506 | 80,935 | 499,312 |
Dec 11 2019 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 4.02 | 113,874 | 457,489 | 3,648,474 |
Dec 11 2019 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 4.02 | 18,729 | 75,244 | 2,877,893 |
Dec 11 2019 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 4.02 | 2,397 | 9,630 | 504,002 |
Nov 26 2019 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 3.40 | 576,097 | 1,958,787 | 3,534,600 |
Nov 26 2019 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 3.40 | 462,056 | 1,571,037 | 2,859,164 |
Nov 26 2019 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 3.40 | 81,857 | 278,322 | 501,605 |
Nov 18 2019 | CALA | Calithera Biosciences, In ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 3.37 | 71,495 | 240,938 | 4,640,838 |
Nov 18 2019 | CALA | Calithera Biosciences, In ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 3.37 | 45,888 | 154,643 | 3,751,608 |
Nov 18 2019 | CALA | Calithera Biosciences, In ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 3.37 | 11,105 | 37,424 | 658,531 |
Nov 07 2019 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 4.00 | 496,721 | 1,986,884 | 2,958,503 |
Nov 07 2019 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 4.00 | 400,470 | 1,601,880 | 2,397,108 |
Nov 07 2019 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 4.00 | 70,921 | 283,684 | 419,748 |
Oct 31 2019 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 3.90 | 1,027 | 4,002 | 2,447,977 |
Oct 31 2019 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 3.90 | 1,133 | 4,415 | 1,985,489 |
Oct 31 2019 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 3.90 | 240 | 935 | 346,867 |
Oct 31 2019 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 3.89 | 10,389 | 40,435 | 2,458,366 |
Oct 31 2019 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 3.89 | 8,236 | 32,055 | 1,993,725 |
Oct 31 2019 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 3.89 | 1,456 | 5,667 | 348,323 |
Oct 31 2019 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 3.85 | 3,416 | 13,150 | 2,461,782 |
Oct 31 2019 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 3.85 | 2,913 | 11,214 | 1,996,638 |
Oct 31 2019 | FPRX | FIVE PRIME THERAPEUTICS, ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 3.85 | 504 | 1,940 | 348,827 |
Oct 31 2019 | CALA | Calithera Biosciences, In ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 2.60 | 872,373 | 2,268,170 | 4,160,751 |
Oct 31 2019 | CALA | Calithera Biosciences, In ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 2.60 | 610,052 | 1,586,135 | 3,374,672 |
Oct 31 2019 | CALA | Calithera Biosciences, In ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 2.60 | 116,552 | 303,035 | 589,558 |
Oct 31 2019 | CALA | Calithera Biosciences, In ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 2.70 | 408,592 | 1,103,198 | 4,569,343 |
Oct 31 2019 | CALA | Calithera Biosciences, In ... | BVF PARTNERS L P/IL | 10% Owner | Buy | 2.70 | 331,048 | 893,830 | 3,705,720 |